Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBMI in Mercury Intoxication
NCT02486289Phase 2Completed
- Sponsor
- EmeraMed
- Start
- Aug 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emeramide in mercury poisoning, sponsored by EmeraMed. Started Aug 2015; status: completed.
02
Drugs
emeramide
03
Conditions
mercury poisoning
Beyond the preview
Go deeper on NCT02486289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486289.